The Use of Human Placental Allografts for Pyoderma Gangrenosum
Therapeutics · 11.03.2026 · 3 (1) · 8
DOI: 10.3390/therapeutics3010008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutics, online erschienen am 11.03.2026. Verfasst von Nicholas Chin und 4 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Pyoderma gangrenosum (PG) is a rapidly progressive, ulcerating condition that can cause large, painful lesions when uncontrolled. There is currently no standard of care treatment for severe PG ulcers refractory to systemic treatment. The present study aims to characterize the outcomes of placental allografts in treating severe PG lesions.
Methods
A single institution retrospective chart review was conducted at the University of South Florida affiliated sites examining PG patients that received placental allograft treatment.
Results
The review returned five patients with clinically diagnosed or biopsy-proven PG treated with placental allograft. In all five patients, application of placental allograft resulted in varying degrees of short-term (
Zitieren
APA
Chin, N., Kallarackal, J., Shenouda, J., Pan, A., & Correa-Selm, L. (2026). The Use of Human Placental Allografts for Pyoderma Gangrenosum. Therapeutics, 3(1), 8. https://doi.org/10.3390/therapeutics3010008
Vancouver
Chin N, Kallarackal J, Shenouda J, Pan A, Correa-Selm L. The Use of Human Placental Allografts for Pyoderma Gangrenosum. Therapeutics. 2026;3(1):8. doi:10.3390/therapeutics3010008
BibTeX
@article{Chin2026,
author = {Chin, Nicholas and Kallarackal, Joel and Shenouda, Jomana and Pan, Adrianne and Correa-Selm, Lilia},
title = {The Use of Human Placental Allografts for Pyoderma Gangrenosum},
journal = {Therapeutics},
year = {2026},
volume = {3},
number = {1},
pages = {8},
doi = {10.3390/therapeutics3010008}
}
EUVIMED